Named on 3 rounds in the feed.
Rounds from 2019-12-10 to 2026-09-01
ROUNDS
3
joined, none as lead
ROUNDS JOINED · USD
$712.0M
across 3 rounds
CO-INVESTORS
31
most often with Bain Capital Life Sciences
Named on 3 rounds in the feed.
Rounds from 2019-12-10 to 2026-09-01
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Tripo AI A generative 3D foundation models company | Series B Verified against 4 of 7 sources | $447.0M | 2026-09-01 | [ PART ] |
Timberlyne Therapeutics Timberlyne Therapeutics develops biopharmaceutical therapies for autoimmune diseases. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $180M | 2025-01-09 | [ PART ] |
Imperative Care Medical devices and technologies for treating strokes and vascular diseases. | Series C Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $85M | 2019-12-10 | [ PART ] |